Iqvia Holdings Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021
July 27, 2021 at 07:00 am EDT
Share
IQVIA Holdings Inc. announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced sales was USD 3,438 million compared to USD 2,521 million a year ago. Operating income was USD 286 million compared to USD 62 million a year ago. Net income was USD 175 million compared to net loss of USD 23 million a year ago. Basic earnings per share from continuing operations was USD 0.91 compared to basic loss per share from continuing operations of USD 0.12 a year ago. Diluted earnings per share from continuing operations was USD 0.9 compared to diluted loss per share from continuing operations of USD 0.12 a year ago. For the half year, sales was USD 6,847 million compared to USD 5,275 million a year ago. Operating income was USD 628 million compared to USD 255 million a year ago. Net income was USD 387 million compared to USD 59 million a year ago. Basic earnings per share from continuing operations was USD 2.02 compared to USD 0.31 a year ago. Diluted earnings per share from continuing operations was USD 1.99 compared to USD 0.3 a year ago.
Iqvia Holdings Inc. is one of the world's leading companies specializing in information, analytics, research and healthcare services based on technology solutions. Net sales break down by activity as follows:
- development of contract research and clinical development solutions and services (54.5%): helping biopharmaceutical companies, medical researchers and healthcare professionals optimize their clinical studies, develop new therapeutic classes, identify treatment needs and assess the efficacy of pharmaceuticals with a view to improving clinical and scientific outcomes;
- development of technology and analytics solutions (39.9%): services related to information, analysis, strategic consulting, marketing studies and short-term healthcare-market studies, business processes outsourcing, and management of medical-administrative databases, all aimed at optimizing the performance and commercial strategies of pharmaceutical companies and health workers;
- integrated services (5.6%): development and implementation of customized solutions and customer engagement programs, healthcare services, scientific and medical services, etc.
Net sales are distributed geographically as follows: Americas (49.4%), Europe and Africa (31.4%) and Asia/Pacific (19.2%).
IQVIA HOLDINGS INC. 
